IMMX
IMMX
US45258H1068
Immix Biopharma, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
784.26M EUR
733.97M EUR
482.94M EUR
276.93M EUR
Enterprise Value
433.49M EUR
509.48M EUR
404.73M EUR
184.08M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-11.16x
--
--
--
Price to Sales
--
--
--
--
Price to Book
2.96x
3.21x
5.72x
2.95x
EV/Revenue
--
--
--
--
EV/EBITDA
-10.45x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-3.24%
-5.33%
-6.79%
-8.27%
ende